Infant Immune Parameters After In-Utero Exposure to Antineoplastic Agents
暂无分享,去创建一个
L. Barness | P. Papenhausen | N. Day | J. Carver | A. Spiers | C. Stromquist | M. Atwood
[1] A. Avilés,et al. Growth and development of children of mothers treated with chemotherapy during pregnancy: Current status of 43 children , 1991, American journal of hematology.
[2] Caligiuri Ma,et al. Pregnancy and leukemia. , 1989 .
[3] Q. S. Ringenberg,et al. Antineoplastic agents and pregnancy. , 1989, Seminars in oncology.
[4] J. Feliu,et al. Association of Leukemia and Pregnancy: Clinical and Obstetric Aspects , 1988, American journal of clinical oncology.
[5] C. Clemm,et al. Chromosomal aberrations in a newborn whose mother received cytotoxic treatment during pregnancy. , 1987, The New England journal of medicine.
[6] J. Mulvihill,et al. Pregnancy outcome in cancer patients. Experience in a large cooperative group , 1987, Cancer.
[7] A. Avilés,et al. Treatment of acute leukemia during pregnancy: presentation of nine cases. , 1980, Cancer treatment reports.
[8] K. Benirschke,et al. Fetal group C trisomy after cytosine arabinoside and thioguanine. , 1971, Annals of internal medicine.
[9] A. Avilés,et al. Long-term follow-up of children born to mothers with acute leukemia during pregnancy. , 1988, Medical and pediatric oncology.
[10] B. Clarkson,et al. Growth and development of children born to patients after cancer therapy. , 1986, Cancer investigation.